Abstract
Major developments in topical therapy for psoriasis have taken place since 1500 B.C. Older methods such as coal tar and anthralin therapy are effective but less popular given difficulty of use. Topical steroids were a revolutionary development for psoriasis. However, they are limited in use due to local and systemic side effects. Non-steroidal topical agents are less efficacious than super-potent topical steroids but have a more favorable side effect profile. Combination medications, such as betamethasone/calcipotriene agents, allow the agents to act synergistically for psoriasis management, while maintaining a safe side effect profile. We recommend a sequential strategy when using a newer combination agent to maximize efficacy and safety, and increase patient compliance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
